Image

Effect of ınhaler Use on Oral Health in COPD Patients

Effect of ınhaler Use on Oral Health in COPD Patients

Recruiting
35-80 years
All
Phase N/A

Powered by AI

Overview

The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.

Description

Before the research data are collected, the purpose, content, scope and duration of the research will be explained in one-to-one interviews with the participants. Verbal and written informed consent will be obtained from the participants. After the participants gave consent to the study, they will be divided into intervention and control groups by simple random sampling method. Participants will be asked to answer the questions in the data collection tools as they see fit and to answer all of the questions. The data collection form will be applied through face-to-face interviews with participants who meet the inclusion criteria. After each completed questionnaire, the researchers will check whether the answers to the survey questions are missing. When unanswered questions are identified, participants will be invited to fill in the missing information. The completion of the questionnaires and training is planned to take an average of 20-25 minutes for each participant. The experimental group will receive training intervention. No education will be given to the control group. After 3 months, an appointment will be made to evaluate oral health

Eligibility

Inclusion Criteria:

  • Diagnosed with COPD for at least 6 months,
  • Outpatient and inpatient,
  • Consent to participate in the research,
  • Not under the age of eighteen,
  • With a metered dose inhaler (MDI) in treatment,
  • No communication barriers,
  • No COPD exacerbation and/or respiratory tract infection,
  • According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).

Exclusion Criteria:

  • Diagnosed with COPD for less than 6 months,
  • Refused to participate in the research,
  • Treatment without metered dose inhalers (MDIs),
  • Uncommunicative,
  • Those who withdrew from participating in the study during data collection,
  • Not completing the survey,
  • COPD exacerbation and/or respiratory tract infection,

Study details
    Chronic Obstructive Pulmonary Disease (COPD)

NCT07000604

Çankırı Karatekin University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.